A 'shield' against cancer
Credit: OHSU News
In a new study, Klaus Früh, Ph.D., left, Louis Picker, M.D., and Scott Hansen, Ph.D., all in OHSU’s Vaccine & Gene Therapy Institute, show that their platform for cytomegalovirus-based vaccines shows promise as a “shield” against cancer. (OHSU/Christine Torres Hicks)